{"version":"1.0","type":"link","title":"First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase I dose exploration.","author_name":"Rodon J 외","author_url":"https://prs-insight.online/author/Rodon%20J","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/155456","thumbnail_width":1200,"thumbnail_height":630}